Introduction p53 is one of the most investigated genes in cancer research due to its critical role in cell death, proliferation, and senescence. p53 protects normal cells from aberrant growth by activating and repressing target genes involved in the control of cellular growth functions. Mutation and/or malfunction of the p53 gene is observed in over half of all human cancers (Hollstein et al., 1991) . While p53 is the most commonly inactivated gene in human malignancy (Olivier et al., 2002) and extensively researched in mammalian models, little is known about its function in lower vertebrate species (Cachot et al., 2004) .
Numerous cellular stressors, such as DNA damage, oncogene activation, hypoxia, growth factor stimulation, and oxidative stress, can activate mammalian p53 (for a review, see Pluquet and Hainaut, 2001) ; this leads to the transcription of one or more of the 60 known downstream p53 target genes (Qian et al., 2002) . Activation of mammalian p53 occurs mainly through post-translational modifications, leading to protein stabilization. Protein stabilization in response to cellular stress allows normally low p53 levels to increase, enabling its role as 'guardian of the genome' (Lane, 1992) by preventing proliferation of damaged cells. Mutations in p53 occur at sites that are crucial to its function, leading to inactivation or abnormal expression (Olivier et al., 2002) .
Although p53 has been found in many lower vertebrates (including 10 bony fish) as well as several invertebrates, information about its specific function in these species is limited. While p53 is highly conserved among mammalian species (74-90%), sequence identity is divergent among lower vertebrate species (38-53%). Among lower vertebrates, however, this divergence is mainly restricted to the amino and carboxy termini, whereas the five DNA-binding domains and crucial residues involved in oligomerization and mdm-2 binding remain highly conserved (Cachot et al., 1998; Kazianis et al., 1998) .
Several key differences in p53 expression and regulation have been described in both lower vertebrates and invertebrates. In mouse models, absence of p53 leads to a high rate of spontaneous tumor formation (Donehower et al., 1992) , as does overexpression of its negative regulator, mdm2 (Jones et al., 1996) . Although this same spontaneous tumor formation is observed in Xenopus embryos injected with mdm2 (Wallingford et al., 1997) , no such tumor formation occurs in zebrafish (Danio rerio) embryos (Thisse et al., 2000) . Upon exposure to DNA-damaging agents, mammalian cells demonstrate an increase in p53 protein, indicative of stabilization due to p53 activation. Although protein stabilization has been demonstrated in Xenopus (Bensaad et al., 2001) , there is no evidence of DNA damageinduced p53 protein increase in fish models examined to date (Jerome Cachot, University of Le Havre, personal communication). Drosophila (Drosophila melanogaster) p53-like protein does not increase upon cellular stress; rather, it is activated through phosphorylation and its function is independent of protein stabilization. Although a p53-like gene can induce apoptosis in Drosophila, it does not control cell cycle arrest as in other species. Together, these findings suggest that important phylogenetic differences may exist both in the function and regulation of p53.
The purpose of this current study was to investigate p53 protein activation in a fish cell culture model. We used a transformed fish hepatoma cell line derived from the desert topminnow (Poeciliopsis lucida) (PLHC-1), a rainbow trout (Oncorhynchus mykiss) normal liverderived cell line (RTL-W1) (Lee et al., 1993) , as well as isolated primary hepatocytes from rainbow trout. Both p53 protein response and apoptosis were measured in fish cells dosed with model chemotherapeutic agents that have been shown to activate p53 in mammalian systems (for a review, see Blagosklonny, 2002) . Our results show that while model mammalian inducers do not increase levels of fish p53 protein, these same chemotherapeutics do induce apoptosis. This study provides further evidence that p53 activation and possible function in fish species may differ from that of other vertebrates.
Results
Fish p53 is recognized by a commercial p53 antibody Owing to the lack of information on fish p53, there are no commercially available antibodies that have been extensively tested for use in fish species. A rabbit polyclonal p53 antibody was tested in fish cell lysates and compared to several mammalian positive controls. The antibody clearly recognized a single band of 53 kDa in fish cell lysates that correlated to the p53 band in MCF7 (human breast cancer), HepG2 (human hepatocellular carcinoma) (Figure 1a , b), A431 (human epidermoid carcinoma), and MK2 (mouse keratinocyte) (data not shown) cell lysates that were used as positive controls.
PLHC-1 p53 is not inducible by model chemotherapeutics Numerous studies in mammalian cells have demonstrated a p53 protein induction upon exposure to various chemotherapeutic agents (Fritsche et al., 1993) . To assess the ability of the fish cell line, PLHC-1, to induce p53 protein in response to similar agents, expression of p53 protein was examined using Western blotting. p53 protein was not induced by the chemotherapy drugs camptothecin (0-20 mM), cisplatin (0-100 mM), etoposide (0-200 mM), 5-fluorouracil (0-25 mM), and mitomycin C (0-25 mM) (Figure 1c-g ) at varying doses following a 24 h exposure. Figure 1a , b demonstrate the typical mammalian cell p53 induction response. Additionally, no protein induction response was observed after 8, 48, or 72-h exposures (data not shown).
Chemotherapeutic agents induce apoptosis in the PLHC-1 cell line p53 plays a major role in the induction of apoptosis, and numerous chemotherapeutic agents lead to apoptosis in both p53-dependent and p53-independent mechanisms. To determine if PLHC-1 cells were susceptible to chemically induced apoptosis despite a lack of p53 protein induction, we measured caspase-3 activity in cells treated for 24 h at similar concentrations used in the immunoblot studies. With the exception of 5-fluorouracil, all of the chemotherapeutic chemicals tested (i.e., camptothecin, cisplatin, etoposide, and mitomycin C) increased caspase-3 activity in a dosedependent manner (Po0.0005) (Figure 2 ). This general trend was also observed with 5-fluorouracil treatment, Lack of p53 induction in fish cells by model chemotherapeutics M Rau Embry et al although it was not statistically significant. Interestingly, the mammalian p53-dependent apoptosis inducers, etoposide and camptothecin, led to apoptosis in these fish cells despite lack of p53 protein induction. Based on known mammalian mechanisms, this suggests that although protein levels were not altered, p53 was activated via an alternate mechanism in response to these exposures. Bleomycin also induced apoptosis in this cell line in a dose-dependent manner (data not shown).
Rainbow trout cell (RTL-W1 cells and primary hepatocytes) p53 is not inducible by chemotherapeutic agents
In order to address the question of whether the lack of p53 inducibility of PLHC-1 cells in response to chemotherapeutics was due to the transformed nature of the cells, we repeated experiments in both a normal liver trout cell line (RTL-W1) and primary trout hepatocytes. Similar to the results observed in PLHC-1 cells, both trout cell types demonstrated lack of p53 protein induction upon exposure to cisplatin (RTL-W1, 0-400 mM), camptothecin (primaries, 0-20 mM), and bleomycin (primaries, 0-100 mM) (Figure 3 ).
Discussion
Compared to mammals, p53 sequence in fish species is highly divergent and its function remains largely unknown. Thus, we investigated possible differences between the well-characterized protein activation response of mammalian p53 to that of piscine p53. Additionally, the low prevalence of p53 mutations found in wild fish (Cachot et al., 2000; Franklin et al., 2000) , as well as in laboratory-exposed fish (Krause et al., 1997; Kazianis et al., 1998; Sueiro et al., 2000) compared to the high prevalence (>50%) of p53 mutations in human cancers (Hollstein et al., 1991; Olivier et al., 2002 ) raises important ques- To address these questions, we first characterized p53 protein response in a widely used fish hepatoma cell line, PLHC-1, using a commercially available p53 polyclonal antibody. In contrast to mammalian systems, where p53 protein is highly induced in response to numerous chemotherapeutic agents (Blagosklonny, 2002) , PLHC-1 p53 protein levels were not induced by a broad range of chemical types, dose, or exposure regimes. As the antibody was of mammalian origin, we also used numerous positive controls (induced mammalian cell extracts (MCF7, A431, MK2, HepG2)) to confirm that the antibody did recognize p53. We were also able to detect the same protein in these same mammalian extracts using a polyclonal antibody against flounder p53 (Cachot et al., 1998) , further validating our results in PLHC-1 (data not shown).
We then examined apoptosis, a cellular function largely regulated by p53, to determine if p53 was activated independently of protein induction in PLHC-1 cells. As shown in Figure 2 , all of the chemotherapeutic agents tested clearly caused a dose-dependent increase in caspase-3 activation. Apoptosis can be initiated in a p53-independent or -dependent manner in mammalian models upon exposure to various chemotherapeutics (Johnstone et al., 2002; Fridman and Lowe, 2003) . Both etoposide and camptothecin are two such chemotherapeutic agents that cause p53-dependent apoptosis in mammalian systems (Matsubara et al., 1999; Wang et al., 1999) . However, in our cell model, camptothecin and etoposide exposures caused apoptosis (Figure 2 ) independent of p53 protein induction (Figure 1 ), suggesting that p53 was activated.
The PLHC-1 cell line was derived from a dimethylbenz(a)anthracene (DMBA)-induced hepatic tumor in the desert topminnow, P. lucida (Hightower and Renfro, 1988) . It is well documented that polycyclic aromatic hydrocarbons (PAHs) such as DMBA can cause p53 mutations and alter biological function (Zambetti and Levine, 1993) . Therefore, it is possible that this cell line could contain mutated p53, and that the lack of p53 induction could be a cell-line-specific response rather than an inherent fish response. To address this possibility, we used two other cell types that were not created through chemical exposure: the RTL-W1 cell line, a rainbow trout liver cell line that retains characteristics of normal liver (Lee et al., 1993) and primary rainbow trout hepatocytes from hatchery-raised fish. In both cell types, p53 protein induction was not induced following exposure to several of the same chemotherapeutics used in the PLHC-1 experiments, indicating that the lack of p53 protein induction was not specific to the PLHC-1 cell line. p53 can also be activated through post-translational modifications, including phosphorylation and acetylation (Appella and Anderson, 2001 ). In mammalian systems, stabilization of p53 protein in response to genotoxic stress is well characterized and is the mechanism by which p53 modulates cell cycle arrest, apoptosis, DNA repair, or other functions in response to DNA damage. The key regulator of p53, murine double minute clone 2 (mdm2), acts through a negative feedback loop to regulate cellular levels of p53. Mdm2 binds to the amino terminus of p53 and functions as an E3 ubiquitin ligase that mediates the proteasomal degradation of p53 (Momand et al., 2000) . Mdm2/p53 binding is mediated by the phosphorylation of p53 and the N-terminal mdm2-binding site as well as other sites, which prevent mdm2 binding and subsequent proteosomal degradation (Colman et al., 2000; Appella and Anderson, 2001; Xu, 2003) . In contrast to mammalian systems, our studies with fish cell lines suggest that while p53 might be activated in response to genotoxic stress, activation is independent of p53 protein stabilization.
Although protein stabilization is the most well-known mechanism by which p53 is activated, other pathways exist that do not involve a p53 protein increase. Stimulation of p53/DNA binding and activation of target genes is also controlled through dephosphorylation events that occur in the carboxy-terminus regulatory domain in response to DNA damage (Caspari, 2000) . Genotoxic stress can also induce phosphorylation and acetylation of p53 at the amino terminus to increase p53 transactivation activity (Yang et al., 2004) . In fact, it has been shown that all of the amino terminal serines and threonines can be phosphorylated or dephosphorylated in response to stress (Appella and Anderson, 2001) , indicating that p53 can be activated in multiple ways.
While the p53 signaling pathway is well understood in mammalian systems, there has been less study of p53 signaling in lower vertebrates, although its role during development has been studied in some detail in Xenopus and zebrafish (Danio rerio). These developmental models have shown several key differences in p53 regulation between the lower vertebrates and mammals. (a) RTL-W1 cells exposed to cisplatin, (b) trout primary hepatocytes exposed to camptothecin, (c) trout primary hepatocytes exposed to bleomycin. p53 protein was detected using a p53 polyclonal antibody (Santa Cruz Biotechnology). For all chemicals and doses, no difference was seen in p53 protein level following treatment.
Lack of p53 induction in fish cells by model chemotherapeutics M Rau Embry et al
While overexpression of mdm2 leads to tumor formation in both mammals (Finlay, 1993) and in Xenopus (Wallingford et al., 1997) , overexpression of mdm2 in zebrafish embryos did not cause tumor development, suggesting phylogenetic differences in p53 regulation and subsequent tumor susceptibility (Thisse et al., 2000) . Xenopus contains a functional mdm2 gene that interacts with p53 in the same manner as in mammals (Marechal, 1997) . Zebrafish mdm2 has been cloned, and while it does interact with p53, it does not contain all of the necessary amino acids crucial for DNA binding in other models (Thisse et al., 2000) . Thus, it is possible that fish regulate p53 activation via an mdm2-independent mechanism.
Drosophila p53-like gene regulation may provide insight into fish p53 regulation. In response to ionizing radiation, Drosophila 'p53', like fish p53, is not induced; however, it has been shown that Drosophila p53 is phosphorylated, and that this phosphorylation is necessary for subsequent apoptosis (Lee et al., 2003) . Drosophila lack an mdm2 homolog, providing further evidence that this species does not regulate p53-like activity through protein stabilization (Sekelsky et al., 2000) .
In conclusion, we have characterized the p53 protein response in three fish cell types in response to chemotherapeutics that lead to p53 protein induction in mammalian systems. Although p53 protein is not induced in fish cells, the apoptotic cascade is activated upon exposure to etoposide, a p53-dependent apoptosis inducer, indicating p53 activation. These responses are not specific to a tumor cell line, as similar results were observed with both a wild-type fish liver cell line and primary hepatocytes. Compared to mammalian studies, our data indicate phylogenetic differences in p53 activation, although these conclusions are speculative in light of the possibility that the apoptotic pathway in fish could significantly differ from that of mammals. These findings do indicate that significant differences may exist between phyla in the function and regulation of p53 as well as other mechanisms involved in carcinogenesis. Additional studies are necessary to further characterize the regulation of p53 and apoptotic signaling in these lower vertebrate species.
Materials and methods

Chemicals
The chemotherapeutic drugs cisplatin, camptothecin, etoposide, and 5-fluorouracil were obtained from Sigma-Aldrich (Milwaukee, WI, USA). Bleomycin was obtained from Calbiochem (San Diego, CA, USA). Bleomycin was dissolved in water to yield a stock solution of 10 mg/ml. All other chemotherapeutic agents were dissolved in dimethylsulfoxide (DMSO) (Sigma-Aldrich, Milwaukee, WI, USA) to yield the appropriate stock solutions. The stock solutions were vortexed briefly and serially diluted in DMSO to yield working solutions of 1000 times the final concentration required by each cell treatment. Solutions were stored at À201C and protected from light.
Animals
Juvenile, reproductively immature rainbow trout (8-10 in, 4-5 months old) were obtained from the North Carolina State Fish Hatchery in Marion, NC, USA. Fish were kept in a 100 L tank with flow-through dechlorinated, filtered, municipal water at a temperature of 181C (12 h light/12 h dark photoperiod). An acclimation period of at least 1 week preceded all experiments. Fish were fed Zeigler (Boston, MA, USA) trout chow pellets on a daily basis.
Cell lines
Poeciliopsus lucida hepatoma cells (PLHC-1) The P. lucida hepatoma cell line (PLHC-1) was obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA) through the Duke University Cell Culture Facility. Cells were grown in T-75 cm 2 flasks at 281C in L-15 media (Life Technologies, Gaithersburg, MD, USA), supplemented with 4 mM L-glutamine, 10% heat-inactivated FBS, and 50 mg/ml gentamicin (Schlenk and Rice, 1998) . Subcultivations were made from confluent flasks with 0.25% trypsin-EDTA (Life Technologies, Gaithersburg, MD, USA).
Rainbow trout liver cell line, RTL-W1 The rainbow trout liver-derived cell line (RTL-W1) was obtained from Dr N Bols (University of Waterloo, Ont, Canada). Cells were grown in T-75 cm 2 flasks at 221C in L-15 media supplemented with 5% FBS and penicillin-streptomycin (20 U/ml-20 mg/ml). Subcultivations were made from confluent flasks with 0.25% trypsin-EDTA.
Primary rainbow trout hepatocytes Primary rainbow trout hepatocytes were isolated as per a modified trypsinization method described by Part et al., 1993 . Briefly, fish were killed by a sharp blow to the head followed by cervical dislocation. Livers were rapidly excised and placed in sterile Ca 2 þ Mg 2 þ -free PBS with antibiotics on ice. Livers were transferred into PBS containing 0.05% trypsin and 0.02% EDTA, minced with scissors, and agitated for 20 min at 200 r.p.m. at room temperature. Following agitation, the tissue was filtered through a 60-mesh cell dissociation sieve (Sigma-Aldrich, Milwaukee, WI, USA) in a solution of PBS plus 10% FBS, centrifuged (300 g for 10 min at 41C), and washed. Cell separation was performed using a modified Percoll gradient method (Sandbacka and Isomaa, 2000) . Briefly, cells were centrifuged (400 g for 25 min at 41C) in a solution consisting of Percoll stock solution (Sigma-Aldrich, Milwaukee, WI, USA), supplemented with 12% NaCl, and the supernatant containing the isolated primary hepatocytes was removed and washed three times in L-15 media. Finally, cells were resuspended in L-15 media supplemented with 5% FBS and antibiotics.
Treatments PLHC-1 and RTL-W1 cells were plated into six-well tissue culture plates and were treated at approximately 80% confluency with selected chemicals for 24 h before assays were performed. Primary trout hepatocytes were plated into T-25 tissue culture flasks upon isolation at a cell density of approximately 20 million cells per flask. Cells were treated with the following chemicals and doses: bleomycin (0-100 mg/ml), camptothecin (0-20 mM), cisplatin (0-100 mM), etoposide (0-200 mM), 5-fluorouracil (0-25 mM), and mitomycin C (0-25 mM). Chemical doses were chosen based on concentrations used in published mammalian studies that demonstrated p53 induction and/or apoptosis (Nelson and Kastan, 1994; Benjamin et al., 1998; Houser et al., 2001; Okamura et al., 2004) . Dose concentrations were lowered if excessive cell mortality was observed.
Western blotting
Following chemical treatment, cell media was aspirated and the cells were washed twice with PBS. NP-40 lysis buffer (10 mM HEPES, pH 7.9, 1 mM EDTA, 1 mM DTT, 1% NP-40, protease inhibitors) was added and cells were incubated on ice for 10 min. The lysed cells were then briefly sonicated and centrifuged at 14 000 r.p.m. for 15 min at 41C. Following centrifugation, supernatant was removed and total protein was measured using the method of Lowry et al. (1951) . In total, 20 mg of total protein was separated on a 10% SDS-PAGE gel and blotted onto nitrocellulose Hybond-C membrane (Amersham Pharmacia Biotech, Piscataway, NJ, USA). The membranes were probed with a rabbit polyclonal p53 antibody (sc-4246) (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and a horseradish peroxidase (HRP)-conjugated goat antirabbit IgG (Jackson Immunoresearch, West Grove, PA, USA). p53 protein was visualized using the ECL kit according to the manufacturer's instructions (Amersham Pharmacia Biotech, Piscataway, NJ, USA).
Apoptosis
Following 24 h treatment with the appropriate chemicals, cells from individual wells of a six-well plate were washed with PBS and trypsinized using 0.25% trypsin-EDTA. The trypsinized cells were pelleted by centrifugation at 300 g for 5 min at 41C and washed twice in PBS. Following the final centrifugation, the PBS was removed and the cell pellet was stored at À801C until analysis. For analysis, the cell pellet was resuspended in 200 ml cell lysis buffer (Biosource International, Camarillo, CA, USA) containing protease inhibitors (1.0 mg/ml leupeptin, 5.0 mg/ml aprotinin, and 1.0 mg/ml pepstatin A) and placed on ice for 10 min. Lysed cells were then centrifuged at 14 000 r.p.m. for 15 min at 41C. In total, 50 ml of the resulting supernatant was added in duplicate to individual wells of a white 96-well plate (Corning Costar, Acton, MA, USA) with 5 ml of 1mM caspase-3 substrate (DEVD-AFC, BioSource International, Camarillo, CA, USA) and 50 ml of 2 Â reaction buffer containing 10 mM DTT (Biosource International, Camarillo, CA, USA). Caspase-3 activity was measured through change in fluorescence over time at excitation and emission wavelengths of 400 and 505 nm, respectively. Readings were performed every 15 min for a 60-105 min period. Final measurements were normalized to protein content.
Statistics
Statistical analyses were performed with StatView s (SAS Institute, Cary, NC, USA) software, using analysis of variance (ANOVA) followed by Fisher's Protected Least Squares Difference post hoc test for individual comparisons. Results were graphed as means7s.e.m.
